Metabolism - Clinical and Experimental
Volume 52, Issue 3 , Pages 261-263 , March 2003

Antihypertensive treatment and homocysteine concentrations

Received 26 April 2002 ,Accepted 28 June 2002.

References 

  1. Nygard O, Nordrehaug JE, Refsum H, et al.  In: Plasma homocysteine levels and mortality in patients with coronary artery disease. 337:1997;p. 230–236
  2. Nygard O, Vollset SE, Refsum H, et al.  Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study JAMA. 1995;274:1526–1533
  3. Jacques PF, Bostom AG, Wilson PW, et al.  Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr. 2001;73:613–621
  4. Dworkin LD. Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens. 2001;10:551–553
  5. Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem. 1991;29:549–554
  6. van Guldener C, Stam F, Stehouwer CD. Homocysteine metabolism in renal failure. Kidney Int Suppl. 2001;78:S234–S237
  7. Joosten E, Lesaffre E, Riezler R. Are different reference intervals for methylmalonic acid and total homocysteine necessary in elderly people?. Eur J Haematol. 1996;57:222–226
  8. Herrmann W, Schorr H, Geisel J, et al.  Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease. Clin Chem Lab Med. 2001;39:739–746
  9. Dierkes J, Westphal S, Luley C. Serum homocysteine increases after therapy with fenofibrate or bezafibrate. Lancet. 1999;354:219–220
  10. Westphal S, Dierkes J, Luley C. Effects of fenofibrate and gemfibrozil on plasma homocysteine. Lancet. 2001;358:39–40
  11. Apeland T, Mansoor MA, Strandjord RE. Antiepileptic drugs as independent predictors of plasma total homocysteine levels. Epilepsy Res. 2001;47:27–35
  12. Fored CM, Ejerblad E, Lindblad P, et al.  Acetaminophen, aspirin, and chronic renal failure. N Engl J Med. 2001;345:1801–1808
  13. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation. 1990;82:1616–1628
  14. Kezdi P, Kezdi PC, Khamis HJ. Diuretic induced long term hemodynamic changes in hypertension. A retrospective study in a MRFIT clinical center. Clin Exp Hypertens A. 1992;14:347–365
  15. Freis ED. The efficacy and safety of diuretics in treating hypertension. Ann Intern Med. 1995;122:223–226

☆ Address reprint requests to Sabine Westphal, MD, Institute of Clinical Chemistry, Leipziger Str 44, D-39120 Magdeburg, Germany.

PII: S0026-0495(02)05276-9

doi: 10.1053/meta.2003.50060

Metabolism - Clinical and Experimental
Volume 52, Issue 3 , Pages 261-263 , March 2003

Article Tools